Stay updated on Losartan and Nivolumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A banner announces that NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T11:22:37.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2; the page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-17T12:09:29.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now shows revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-10T13:03:01.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error screen, replacing the usual study record content with an access-denied notice.
    Difference
    22%
    Check dated 2026-09-19T22:26:46.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.5 to v3.6.6, signaling a small backend or content update.
    Difference
    0.0%
    Check dated 2026-08-29T18:49:51.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added to the page, indicating an update to the study record. A large set of core trial details, including the listed interventions (Nivolumab, Losartan, FOLFIRINOX) and related MeSH terms, were removed from the study record, altering the displayed scope of the trial.
    Difference
    21%
    Check dated 2026-08-08T19:26:48.000Z thumbnail image

Stay in the know with updates to Losartan and Nivolumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.